BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25859857)

  • 1. Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? A large-scale retrospective study.
    Hu T; Li X; Zhang Q; Huang K; Jia Y; Yang R; Tang F; Tian Q; Ma D; Li S
    PLoS One; 2015; 10(4):e0123539. PubMed ID: 25859857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
    Xiong Y; Liang LZ; Cao LP; Min Z; Liu JH
    Gynecol Oncol; 2011 Oct; 123(1):99-104. PubMed ID: 21741694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the clinical efficacy of different treatments based on radical surgery in stage Ⅰ b2 and Ⅱa2 cervical cancer: a prospective randomized control study].
    Li X; Kong WM; Han C; Yan Z; Zhao H; Zhang WY; Wang JD
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):524-9. PubMed ID: 27465872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
    Gong L; Lou JY; Wang P; Zhang JW; Liu H; Peng ZL
    Int J Gynaecol Obstet; 2012 Apr; 117(1):23-6. PubMed ID: 22265255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical-pathologic risk factors of pelvic lymph node metastasis in stage Ib1-IIb cervical cancer.
    Li D; Cai J; Kuang Y; Cao J; Wang Z
    Acta Obstet Gynecol Scand; 2012 Jul; 91(7):802-9. PubMed ID: 22486458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: an Italian multicenter retrospective study (CTF Study).
    Gadducci A; Sartori E; Maggino T; Zola P; Cosio S; Zizioli V; Lapresa M; Piovano E; Landoni F
    Gynecol Oncol; 2013 Dec; 131(3):640-4. PubMed ID: 24096111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Number of Positive Pelvic Lymph Nodes and Multiple Groups of Pelvic Lymph Node Metastasis Influence Prognosis in Stage IA-IIB Cervical Squamous Cell Carcinoma.
    Liu Y; Zhao LJ; Li MZ; Li MX; Wang JL; Wei LH
    Chin Med J (Engl); 2015 Aug; 128(15):2084-9. PubMed ID: 26228223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is intraoperative frozen section analysis of pelvic lymph nodes accurate after neoadjuvant chemotherapy in patients with cervical cancer?
    Bader AA; Winter R; Moinfar F; Petru E; Pristauz G; Scholz HS; Haas J; Tamussino KF
    Gynecol Oncol; 2006 Oct; 103(1):106-12. PubMed ID: 16564076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.
    Eddy GL; Bundy BN; Creasman WT; Spirtos NM; Mannel RS; Hannigan E; O'Connor D
    Gynecol Oncol; 2007 Aug; 106(2):362-9. PubMed ID: 17493669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy for locally advanced cervical cancer reduces surgical risks and lymph-vascular space involvement.
    Wang Y; Wang G; Wei LH; Huang LH; Wang JL; Wang SJ; Li XP; Shen DH; Bao DM; Gao J
    Chin J Cancer; 2011 Sep; 30(9):645-54. PubMed ID: 21880186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer.
    Behtash N; Nazari Z; Ayatollahi H; Modarres M; Ghaemmaghami F; Mousavi A
    Eur J Surg Oncol; 2006 Dec; 32(10):1226-30. PubMed ID: 16952434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteria.
    Hu T; Li S; Chen Y; Shen J; Li X; Huang K; Yang R; Wu L; Chen Z; Jia Y; Wang S; Cheng X; Han X; Lin Z; Xing H; Qu P; Cai H; Song X; Tian X; Xu H; Xu J; Zhang Q; Xi L; Deng D; Wang H; Wang S; Lv W; Wang C; Xie X; Ma D
    Eur J Cancer; 2012 Oct; 48(15):2353-60. PubMed ID: 22503395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.
    Hu T; Wu L; Xing H; Yang R; Li X; Huang K; Jia Y; Zhang Q; Chen Z; Wang S; Liu D; Han X; Lin Z; Qu P; Cai H; Song X; Tian X; Wang H; Wang S; Xie X; Li S; Ma D
    Ann Surg Oncol; 2013 Mar; 20(3):881-90. PubMed ID: 23054110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of cell apoptosis in pelvic lymph nodes of patients with cervical cancer after neoadjuvant chemotherapy.
    Zhang H; Peng W; Zhang Y
    J Int Med Res; 2014 Jun; 42(3):641-50. PubMed ID: 24651993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Neoadjuvant Chemotherapy Plus Radical Surgery as Front Line Treatment Strategy in Patients Affected by FIGO Stage III Cervical Cancer.
    Di Donato V; Schiavi MC; Ruscito I; Visentin VS; Palaia I; Marchetti C; Fischetti M; Monti M; Muzii L; Benedetti Panici P
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):841-849. PubMed ID: 27678502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis.
    Akita H; Doki Y; Yano M; Miyata H; Miyashiro I; Ohigashi H; Ishikawa O; Nishiyama A; Imaoka S
    Dis Esophagus; 2009; 22(4):291-7. PubMed ID: 19021686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
    Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic versus robotic radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical cancer: a case control study.
    Vizza E; Corrado G; Mancini E; Vici P; Sergi D; Baiocco E; Patrizi L; Saltari M; Pomati G; Cutillo G
    Eur J Surg Oncol; 2015 Jan; 41(1):142-7. PubMed ID: 24063966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
    Li X; Zhou J; Huang K; Tang F; Zhou H; Wang S; Jia Y; Sun H; Ma D; Li S
    PLoS One; 2015; 10(4):e0122361. PubMed ID: 25860888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.